Skip to main content
OpenTrials
Completed

NCT Number: NCT01679548

Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease

To compare the efficacy between single-port and three-port laparoscopic assisted vaginal hysterectomy in patients with benign or preinvasive uterine disease

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–70 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center

Seoul, 138-736, South Korea

About this study

This study intended to conduct a randomized trial to determine whether LESS LAVH has a faster recovery rate than three-port LAVH.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient who undergo laparoscopic assisted vaginal hysterectomy due to following gynecologic disease
  • uterine leiomyoma
  • uterine adenomyosis
  • Endometrial hyperplasia
  • cervical intraepithelial neoplasia including carcinoma in situ
  • Dysfunctional uterine bleeding
  • Other benign gynecologic disease requiring hysterectomy
  • American Society of Anesthesiologists Physical Status classification I-II
  • Patient who have signed an written informed consent

Exclusion criteria

  • Uncontrolled medical disease
  • Active infectious disease
  • Previous pelvic radiation therapy
  • Patient who requiring further procedure excluding hysterectomy, unilateral or bilateral salpingooophorectomy / salpingectomy / oophorectomy
  • Patient who undergoes subtotal hysterectomy
  • Patient who have other pain source excluding gynecologic disease
  • Pregnancy and lactating woman

Treatment and study plan

Single-port LAVH

Procedure

LESS LAVH was performed using a commercially available four-channel, single-port system. A rigid, 0-degree, 5 mm laparoscope was used.

Three-port LAVH

Procedure

Conventional LAVH was performed using three ports; a 12, 10, and 5-mm port was placed in the umbilicus, left lower quadrant, and suprapubic area, respectively. A rigid, 0-degree, 12 mm laparoscope was introduced through 12mm port of umbilicus.

Primary outcomes

  1. postoperative hospital stay

    Time frame: within 1 week after surgery

    The primary endpoint was to compare average length of postoperative hospital stay and the ratio of patients discharged within 2 days after surgery between LESS and conventional groups.

Secondary outcomes

  1. postoperative pain

    Time frame: within 1 week after surgery

    Postoperative pain was recorded using the Visual Analog Pain Scale (VAS), scored from 1 to 10 (0 is no pain and 10 is agonizing pain)

  2. postoperative analgesics requirement

    Time frame: within 1 week after surgery

    Whenever patients requested additional analgesia, they were administered parenterally.

  3. operating time

    Time frame: 1 day (immediately ater surgery)

    skin to skin operation time was recorded

  4. Transfusion requirement and amount

    Time frame: within 1 week after surgery

    Transfusion requirement and amount were recorede

  5. intra and postoperative complication

    Time frame: within 1 months after surgery

    intra and post operative complications were recorede

Sponsors and collaborators

Lead sponsor

Asan Medical Center

Other

Registry information

Official study title

Prospective Randomized Comparison of Single-port and Three-port Laparoscopic Assisted Vaginal Hysterectomy

Important dates

Study start
2012
Primary completion
2018
Study completion
2019
First posted
Sep 6, 2012
Registry last updated
Mar 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.